Accolade - which is backed by $200 million in venture funds, and with 500 of its 850 employees in Plymouth Meeting - seeks to cut the corporate health-care costs that Warren Buffett says are "tapeworm" eating away at private industry's profits.
Philly.com Business, Philadelphia Inquirer & Daily News: Business
Thu, 07/12/2018 - 6:46am
Accolade - which is backed by $200 million in venture funds, and with 500 of its 850 employees in Plymouth Meeting - seeks to cut the corporate health-care costs that Warren Buffett says are "tapeworm" eating away at private industry's profits.